Skip to main content

2 Result(s)

within Siying Xu Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors

    Envafolimab is the first and only globally approved subcutaneously injectable PD-L1 antibody. This open-label, multicenter Phase 1 trial assessed the safety, tolerability, pharmacokinetic (PK) profile, and eff...

    Toshio Shimizu, Takako Eguchi Nakajima, Noboru Yamamoto… in Investigational New Drugs (2022)

  2. No Access

    Article

    Normative anthropometric analysis and aesthetic indication of the ocular region for young Chinese adults

    The ocular region is of prime importance for the facial aesthetic outlook. Various anthropometric analyses for the periocular region have developed to ensure a pleasing postoperative appearance. However, littl...

    Qian Li, **nchun Zhang, Kang Li, Yadan Quan… in Graefe's Archive for Clinical and Experime… (2016)